CALT - Calliditas's Kinpegyo gets EU approval setanaxib study meets endpoint
2024-07-26 15:52:19 ET
More on Calliditas Therapeutics
- Asahi Kasei To Pay A Fair Price For Calliditas Therapeutics
- Calliditas Therapeutics AB (publ) (CALT) Q1 2024 Earnings Call Transcript
- Calliditas Therapeutics AB (publ) 2024 Q1 - Results - Earnings Call Presentation
- Citi downgrades Calliditas to neutral, cites takeover offer
- Asahi Kasei offers to buy Calliditas Therapeutics for $1.1B